A New Twist on a Classic: Enhancing Radioiodine Uptake in Advanced Thyroid Cancer.
1/5 보강
Advanced differentiated thyroid cancer that is resistant to radioactive iodine therapy may become responsive with a unique treatment combination of chloroquine and vorinostat.
APA
Lechner MG, Brent GA (2024). A New Twist on a Classic: Enhancing Radioiodine Uptake in Advanced Thyroid Cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research, 30(7), 1220-1222. https://doi.org/10.1158/1078-0432.CCR-23-3503
MLA
Lechner MG, et al.. "A New Twist on a Classic: Enhancing Radioiodine Uptake in Advanced Thyroid Cancer.." Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 30, no. 7, 2024, pp. 1220-1222.
PMID
38197869 ↗
Abstract 한글 요약
Advanced differentiated thyroid cancer that is resistant to radioactive iodine therapy may become responsive with a unique treatment combination of chloroquine and vorinostat. This treatment was demonstrated in cellular and animal models of thyroid cancer to inhibit endocytosis of the plasma membrane-bound iodine transporter, NIS, and restore iodine uptake. See related article by Read et al., p. 1352.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (2)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- SpNeigh: spatial neighborhood and differential expression analysis for high-resolution spatial transcriptomics.
- Key Considerations for Targeting in Pancreatic Cancer: Potential Impact on the Treatment Paradigm.
- The tumor microenvironment as a key regulator of radiotherapy response.
- Overcoming Chemoresistance in Glioblastoma: Mechanisms, Therapeutic Strategies, and Functional Precision Medicine.